INTRODUCTION 23 24
In spite of the discovery of Trichomonas vaginalis nearly 175 years ago and documentation of 25 its inhabitation of the female urogenital tract and the male urinary tract in the late 1800s, 26 pathogenicity was not ascribed to this agent until the European literature of the 20th century 27 [19] . Reports have since shown the significance of antecedent T. vaginalis infection, 28 especially in human immunodeficiency virus (HIV) co-infection [22, 36] , acquisition [21] , 29 and transmission [17, 23] ; in pregnancy-related complications [10, 43] ; and in associations 30 with pelvic inflammatory disease [16] and Neisseria gonorrhoeae infection [16, 24] . T. 31 vaginalis is currently thought to be responsible for approximately 50% of all curable 32 infections worldwide [5] ; worldwide estimates of annual trichomoniasis incidence have 33 reached 180 million cases [41] . 34 
35
While the aforementioned data may be of tremendous significance, trichomoniasis prevalence 36 rates, both worldwide and in the United States, are thought to be grossly underestimated. 37 Schwebke and Burgess [31] hypothesize that the variable sensitivity of T. vaginalis diagnostic 38 testing contributes partially to these artificially low statistics. Direct examination of genital 39 saline collections continues to serve as a common basis for laboratory detection of T. 40 vaginalis, with assay sensitivity inherently low (approximately 50-70%) due to its 41 dependency upon live, motile flagellates. Nucleic acid hybridization [2] , antigen detection 42 [20] , and culture [4, 12] modalities have enhanced analytical sensitivity rates up to 50%, 43 although such improvement has been offset by the advent of T. vaginalis-specific nucleic acid 44 amplification testing (NAAT) [35, reviewed in 31] . 45 Hardick et al. [15] reported that transcription-mediated amplification (TMA) exhibited >96% 47 sensitivity and specificity in the detection of T. vaginalis in a sexually-transmitted disease 48 (STD) clinic setting. Similar levels of TMA sensitivity and specificity were demonstrated in a 49 study of adolescent women recruited during presentation at an emergency department or teen 50 health center [18] . We report findings of a retrospective study that examined potential utility 51 of TMA on routine T. vaginalis detection within a regional healthcare system (having 52 substantive basis in emergent care and family practice) that is centered in a metropolitan area 53 of high STD prevalence. 54 the proportion collected within the outpatient physician group (46.8%) was similar to the 135 percentage of direct saline preparations in the audit originating from that entity (P = 0.06). A 136 proportional rate of specimens from emergency department A (39.7%), the urgent-care 137 facility (7.1%), and emergency department B (6.4%) were selected for the evaluation (P ≥ 138 0.22 versus corresponding audit data). 139
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140
The frequency distribution of provider-performed and laboratory-performed direct saline 141 preparations within the outpatient physician group was not significantly different between the 142 evaluation specimens and those captured by the audit (P = 0.52). Rates of T. vaginalis 143 detection derived from point-of-care and laboratory-based examination of direct saline 144 preparations were not significantly different between data collected in the audit and those 145 associated with the evaluation specimens (P ≥ 0.66). 146
147
The overall rate of positive direct saline preparation result in evaluation specimens (7.0%; 148 Table 1 ) did not significantly differ from the rate documented in the audit (6.8%; P = 0.84). 149
When delineated by healthcare entity, rates did not significantly differ (P ≥ 0.23). In similar 150 fashion, comparison of audit and evaluation data revealed no significant differences in entity-151 specific rate of C. trachomatis (P ≥ 0.55) and N. gonorrhoeae (P ≥ 0.58) detection. Overall 152 Hispanic/Latino ethnicity to Black/African American race in the population served by 172 emergency department B was documented (Fig. 1D) . 173 vaginalis direct saline preparation result generated a positive molecular ASR result. In 176 addition, 82 direct saline preparation-negative specimens yielded a positive result with the 177 molecular ASR, establishing an overall molecular detection rate of 14.5%. Molecular ASR 178 detection rates ranged from 6.5% at the urgent-care facility to 21.6% at emergency 179 department A ( setting. The rate of T. vaginalis detection by molecular ASR was more than double that of the 215 direct saline preparation (P = 0.02 versus provider-performed microscopy; Table 3) . 216
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Similarly, a 12.0% rate of detection by molecular ASR was observed in 241 specimens 217 originally subjected to direct saline preparation in the laboratory (P = 0.002 versus 218 microscopy). 219 especially N. gonorrhoeae [16, 24] , are frequently co-detected with T. vaginalis, a potentially 230 high T. vaginalis prevalence throughout this entire community setting was deduced, providing 231 a multi-faceted demographic to investigate the impact of molecular ASR. Furthermore, 232
analysis of an in toto healthcare population is pertinent, when compared to the focused study 233 of adolescent women [18] , because trichomoniasis is observed with significant frequency over 234 an expansive range of age groups [24, 25] . 235
236
With this investigation being retrospective in nature, the study set was validated using three 237 approaches. First, raw percentages of specimens selected from each of the four healthcare 238 entities did not differ (P ≥ 0.06) from analogous percentages realized during the six-month 239 audit of T. vaginalis diagnostic practices. Secondly, entity-specific incidence of N. between evaluation and audit data. Within this community-wide population, the T. vaginalis 244 molecular ASR detection rate (14.5%) more than doubled that yielded by direct saline 245 preparation (7.0%). These data extend the findings of Huppert et al. [18] who reported a 246 nearly two-fold increase of T. vaginalis detection (9.4% to 18.1%) upon utilization of TMA. 247
248
In our study, alternative target TMA was performed on a subset of the direct saline 249 preparation-negative/molecular ASR-positive specimens and generated 100% concordance for 250 presence of T. vaginalis. This alternative target assay was performed in the context of a 251
Centers for Disease Control and Prevention (CDC) recommendation for confirmation of C. 252
trachomatis-and N. gonorrhoeae-specific NAAT [6] . In a subset of 65 molecular ASR-253 negative specimens, the T. vaginalis-specific alternative target TMA showed a slight 254 proclivity for generating positive results (P = 0.08). These data mirror those previously 255 published for C. trachomatis- [26, 30] and N. gonorrhoeae-specific [26] alternative target 256 TMA and likely reflect the high analytical sensitivity of the method [8] . Repeat molecular 257 ASR testing was also used in our study to confirm the presence of T. vaginalis within 258 specimens yielding discordant results. Huppert et al. [18] repeated TMA analysis on all 259 positive specimens. The fact that repeat TMA performance on primary specimens has been 260 espoused for C. trachomatis- [26, 30] and N. gonorrhoeae-specific NAAT [26] Of the two urban emergency departments studied, only emergency department A showed a 265 significant increase of T. vaginalis detection by molecular ASR over that observed by direct 266 saline preparation. For a variety of cultural, socioeconomic, and intrinsic reasons, an elevated 267 rate of trichomoniasis has been reported in Black/African American women [37] . In our 268 study, Black/African American race comprised a higher proportion of the emergency 269 department A demographic than that of emergency department B (P < 0.0002; Fig. 1) . The 270 21.6% T. vaginalis incidence rate derived by molecular ASR testing of patients from 271 emergency department A was similar to the 18.1% incidence rate from a TMA-based analysis 272 of an emergent care population that was 82% Black/African American [18] commonly co-detected with T. vaginalis [16, 24] . Our study corroborates these data to a 286 certain extent by demonstrating an elevated odds ratio for concomitant N. gonorrhoeae 287 detection in genital specimens yielding T. vaginalis upon direct saline preparation (Table 2) . 288
However, performance of T. vaginalis molecular ASR on the same study set revealed 289 significant odds ratios for simultaneous C. trachomatis or N. gonorrhoeae detection (P < 290 0.0001). Huppert et al. [18] , when using a composite reference standard for T. vaginalis 291 (including NAAT), reported significant rates of individual C. trachomatis and N. gonorrhoeae 292 co-detection with T. vaginalis. Taken together, these data suggest that T. vaginalis molecular 293 ASR has greater potential to predict a simultaneous sexually-transmitted agent and may even 294 benefit clinicians with respect to follow-up ordering practices. 295
296
In this vein, the T. vaginalis molecular ASR was evaluated using the same endocervical 297 specimen utilized for C. trachomatis-and N. gonorrhoeae-specific TMA. 97.4% of 78 298 patients with a positive direct saline preparation of a vaginal collection yielded a positive 299 molecular ASR result from the contents of the APTIMA® swab specimen transport tube. The 300 two T. vaginalis direct saline preparation-positive/molecular ASR-negative results (confirmed 301 as negative by both repeat testing and alternative target TMA) suggest a false-positive direct 302 saline preparation, a scenario that has been previously described [4, 13, 29] . T. vaginalis 303 detection from vaginal saline collections by molecular ASR has correlated with TMA analysis 304 of a separate endocervical collection [27] . To further support the validity of this specimen 305 source, Papanicolaou-stained smears have reasonable success in the detection of T. vaginalis 306 [42] . Other studies [28, 29] , incorporating varying reference standards, reported an 307 approximate 10% T. vaginalis recovery rate from culture of endocervical specimens. saline preparation of vaginal collections may not be completely discounted in the assessment 312 of female lower genital disease. Our data ascribe excellent predictive value to a positive 313 microscopic result (Fig. 3) , suggesting a role for the direct saline preparation as a rapid 314 screening assay within a molecular reflex testing algorithm. While NAAT had previously 315 been considered non-advantageous for T. vaginalis testing in females because of purported 316 reliability of culture [31] , the converse now appears to hold true. This likely represents a 317 corollary of studies in multiple disease agents [8, 9] that have documented greater analytical 318 sensitivity of TMA over that of PCR. 319 320 Viability of the trophozoite following specimen transport may be a significant factor in (non-321 office) laboratory-based microscopic detection of T. vaginalis [13] . Direct saline preparation 322 sensitivity rates may also be impacted by acumen of non-laboratory microscopists, some of 323 whom may have experienced inadequate training [11] or lack of participation in proficiency 324 testing programs and competency assessments [38, 39] . Data from the outpatient physician 325 group (Table 3) Fouts and Kraus [12] reported that nearly 50% of women infected with T. vaginalis are 333 asymptomatic; one-third of these individuals progress to a symptomatic state within six 334 months [16] . Schwebke and Hook [32] 
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